1. Events
  2. Venues
  3. Virtual
Virtual Get Directions
Current

CytoSorbents Virtual KOL and Analyst-Investor Day: A Review of STAR-T Pivotal Trial Results with DrugSorb-ATR & Real World Experience with Antithrombotic Drug Removal in Europe

Join CytoSorbents for a virtual KOL and Analyst-Investor Day, featuring Michael J. Mack, MD (Baylor Scott & White Health), C. Michael Gibson,…
TIME: 11:30 AM EDT
LOCATION: Virtual
View Details

Theravance Biopharma KOL Event to Discuss Ampreloxetine’s Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Join Theravance Biopharma for a virtual KOL event featuring Horacio Kaufmann, MD, FAAN (Felicia B. Axelrod Professor of Neurology and Professor…
TIME: 10:00 AM EDT
LOCATION: Virtual
View Details

Sagimet Biosciences Virtual Investor and Analyst Day: Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH

Sagimet announced positive topline data from its FASCINATE-2 Phase 2b trial of denifanstat in MASH in Jan '24 and plans…
TIME: 12:30 PM EDT
LOCATION: Virtual
View Details